Načítá se...
Targeted therapies to improve CFTR function in cystic fibrosis
Cystic fibrosis is the most common genetically determined, life-limiting disorder in populations of European ancestry. The genetic basis of cystic fibrosis is well established to be mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that codes for an apical membrane chl...
Uloženo v:
| Vydáno v: | Genome Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582929/ https://ncbi.nlm.nih.gov/pubmed/26403534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-015-0223-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|